GlycoRegImmune Inc. (GRI Bio), a biotech developing treatments for inflammatory disease, recently raised $4.38 million in equity financing, according to a recent regulatory filing.
Researchers have found a novel avenue for therapeutic intervention of pancreatic cancer – the “silent cancer.”
Sanford-Burnham researchers recently discovered a key role of a protein called SOX2 in neuronal development. SOX2 promotes the activation of genes involved in differentiation, enabling neural progenitor cells to turn into mature neurons in the brains o…
New research shows that antioxidants may improve beta cell functions and glucose metabolism in type 2 diabetes.
CA-San Diego, Research Scientist/Associate Chemtron Biotech is seeking a Research Scientist/Associate with strong interpersonal communication skills to lead a R&D team through the product development cycle of IVD tests for market. The Research Scientist/Associate will be responsible for the development of immunoassay tests in the drugs of abuse field for FDA submission and clearance. This position reports to t
Fast growing web marketing company that provides websites, social media, SEO and paid search solutions to the businesses throughout the country is seeking a Sales Representative to contact prospective clients and schedule online appointments for a de […
CA-San Diego, Marketing/Sales Associate Chemtron Biotech is a manufacturing based company for IVD rapid tests and are currently looking to expand our sales and marketing efforts to increase our brand name and international reach. We are looking for a c…
Maintains a master MRP schedule to support production and development. GMP and ISO standards relating to materials….
From Indeed – 21 Apr 2015 15:21:54 GMT
– View all San Diego jobs
New study finds no link between autism and MMR vaccination, even in high-risk children.
SAN DIEGO, CA–(Marketwired – Apr 21, 2015) –
Invivoscribe Technologies, Inc. (IVS) anunció hoy el lanzamiento comercial de cuatro ensayos de secuenciación de próxima generación (NGS) LymphoTrack(R) Dx, con marca CE, utilizados para detectar el receptor de células T gamma (TRG) y los reordenamientos de los genes de las cadenas pesadas de las inmunoglobulinas (IGH). Estos kits de pruebas de diagnóstico in vitro (IVD), validados para su uso con los instrumentos Illumina MiSeq(R) y ThermoFisher Ion PGM(TM), comprenden solo algunos de los ensayos LymphoTrack Dx con marca CE que Invivoscribe intenta lanzar este año.